News

La Marató will finance with 1.5 million euros 10 IDIBELL projects in rare diseases

IDIBELL has been one of the institutions with more funded projects, up to 10, of which it leads 7, and participates in 3 more projects as a collaborator.

Leer más about La Marató will finance with 1.5 million euros 10 IDIBELL projects in rare diseases

New biomedical breakthroughs of Bellvitge, live streaming on November 28th

Next Saturday, November 28th, researchers of Bellvitge will present their most recent investigations to the general public. The new website Sinergia will broadcast a wide program of virtual talks. Sinergia has been specifically released to celebrate the first virtual edition of the Festival for the Research and Innovation in Health of L’Hospitalet.

Leer más about New biomedical breakthroughs of Bellvitge, live streaming on November 28th

The combination of two immunomodulatory drugs could be beneficial for more severe Covid-19 patients

A total of 44 researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and Bellvitge University Hospital (HUB) sign an article in the International Journal of Infectious Diseases, where they demonstrate the beneficial effect of the use of corticosteroids added to tocilizumab treatment to improve the prognosis of critical patients of Covid-19.

Leer más about The combination of two immunomodulatory drugs could be beneficial for more severe Covid-19 patients

Some drugs used to reduce stomach acid may increase false positives in the colon and rectal cancer screening

A new study analyzes the influence of proton pump inhibitor drugs on the risk of false positives in an immunological fecal occult blood test, a test used to detect colorectal cancer.

Leer más about Some drugs used to reduce stomach acid may increase false positives in the colon and rectal cancer screening

Bellvitge will study the application of artificial intelligence in the treatment of Covid-19 in ICUs

The Intensive Medicine Service of the Bellvitge University Hospital (HUB) participates, through the Bellvitge Biomedical Research Institute (IDIBELL), in the European ENVISION project, which will develop an intelligent decision support system to improve the monitoring and treatment of patients with Covid-19 in ICUs.

Leer más about Bellvitge will study the application of artificial intelligence in the treatment of Covid-19 in ICUs

IDIBELL celebrates the Kickoff Meeting of the projects financed by 2019 La Marató de TV3 Foundation call

Today, the Teams platform hosted the IDIBELL Kickoff Meeting La Marató 2019, aimed at all those researchers who have obtained a research project within the “Convocatòria 2019 per a l’adjudicació d’ajudes econòmiques a projectes de recerca de càncer” by La La Marató de TV3 Foundation.

Leer más about IDIBELL celebrates the Kickoff Meeting of the projects financed by 2019 La Marató de TV3 Foundation call

New global strategy to eliminate cervical cancer

This milestone could be achieved thanks to the increased efficacy and mass administration of the vaccine as well as the modernization of screening techniques.

Leer más about New global strategy to eliminate cervical cancer

Today Sinergia, a new website for the dissemination of health research and innovation in L’Hospitalet, is launched

Among the activities proposed by Sinergia are a virtual escape room through the IDIBELL laboratories, family workshops and 360º visits to Bellvitge facilities.

Leer más about Today Sinergia, a new website for the dissemination of health research and innovation in L’Hospitalet, is launched

The impact of the pandemic on people with eating disorders and obesity

Dr. Fernando Fernández-Aranda is currently the editor-in-chief of the European Eating Disorders Review, a journal that has published a special issue in October focusing on the impact of the pandemic and lockdown on patients with eating disorders and obesity. We spoke with Dr. Fernández-Aranda about this special and the reflections they have extracted.

Leer más about The impact of the pandemic on people with eating disorders and obesity
Scroll to Top